AbbVie says deaths in arthritis trial not linked to drug Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTAbbVie Inc said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug,...
Regeneron, Sanofi asthma drug data fails to excite investors Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTPARIS: Shares of Regeneron Inc and Sanofi SA slid on Monday after late-stage trial data for their asthma drug, dupilumab, fell short of investor...
Drugmaker Teva hires Lundbeck CEO Schultz to restore its health Ruby Khatun Khatun12 Sept 2017 9:47 AM ISTJERUSALEM/COPENHAGEN: Teva poached Lundbeck's Kare Schultz as its new chief executive on Monday, handing the drugs industry veteran the urgent task of...
Novo Nordisk settles US probe over diabetes drug for nearly 58.7 million dollar Ruby Khatun Khatun7 Sept 2017 10:48 AM ISTNovo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of U.S. Food and Drug...
Novartis hopeful for novel heart drug, despite modest benefit Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTZURICH: Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection...
FDA approves Mavyret for Hepatitis C Ruby Khatun Khatun10 Aug 2017 9:45 AM ISTThe U.S. Food and Drug Administration (FDA) approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV)...
Google bets on European biotech drugs, backs new fund Ruby Khatun Khatun19 Jun 2017 9:26 AM ISTLONDON: Google is betting on the potential of European biotech companies to deliver life-changing drugs by investing alongside Swiss company Novartis...
FDA rejects Coherus' biosimilar for Amgen's Neulasta Ruby Khatun Khatun13 Jun 2017 9:12 AM ISTn" style="transform: translate3d(0px, 0px, 0px);"Coherus BioSciences Inc said on Monday the U.S. Food and Drug Administration (FDA) denied the...
